Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays

https://doi.org/10.1016/j.pep.2020.105686Get rights and content

Highlights

  • Improved yields of SARS-CoV-2 spike protein through modification of expression and purification parameters.

  • Yields of greater than 5 mg/l obtained for VRC spike under optimal conditions.

  • Spike protein quality was validated by QC methods to ensure utility in serology assays.

Abstract

The SARS-CoV-2 spike trimer is the primary antigen for several serology assays critical to determining the extent of SARS-CoV-2 exposure in the population. Until stable cell lines are developed to increase the titer of this secreted protein in mammalian cell culture, the low yield of spike protein produced from transient transfection of HEK293 cells will be a limiting factor for these assays. To improve the yield of spike protein and support the high demand for antigens in serology assays, we investigated several recombinant protein expression variables by altering the incubation temperature, harvest time, chromatography strategy, and final protein manipulation. Through this investigation, we developed a simplified and robust purification strategy that consistently yields 5 mg of protein per liter of expression culture for two commonly used forms of the SARS-CoV-2 spike protein. We show that these proteins form well-behaved stable trimers and are consistently functional in serology assays across multiple protein production lots.

Keywords

SARS-CoV-2
COVID-19
Spike protein
ELISA
Serology
Protein production

Abbreviations

AnSEC
analytical size exclusion chromatography
CV
column volume
ELISA
enzyme-linked immunosorbent assay
IMAC
immobilized metal ion affinity chromatography
RBD
receptor binding domain
SEC
size exclusion chromatography
SDS-PAGE
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
TEM
transmission electron microscopy
TFF
tangential flow filtration
VRC
Vaccine Research Center

Cited by (0)

View Abstract